Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Toth

Showing results (41-50 of 524) with videos related to

Pageof 53
Sort By:
Clinical Therapeutics|November 9, 2004
Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalonePeter P Toth, Jason Urtis
Methodist Debakey Cardiovascular Journal|May 4, 2019
Statins: Then and NowPeter P Toth, Maciej Banach
Current Atherosclerosis Reports|August 12, 2009
Thienopyridine therapy and risk for cardiovascular events in secondary preventionPeter P Toth, Annemarie Armani
Ecotoxicology (London, England)|August 15, 2001
Development of DNA-based microsatellite marker technology for studies of genetic diversity in stressor impacted populationsP Dimsoski, G P Toth
Postgraduate Medicine|November 2, 2020
Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care systemPeter P Toth, Diane Gauthier
Current Atherosclerosis Reports|November 16, 2007
SPARCL: the glimmer of statins for stroke risk reductionAnnemarie Armani, Peter P Toth
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 1, 1994
Clozapine and seizures: a reviewP Toth, F R Frankenburg
Expert Review of Cardiovascular Therapy|May 24, 2006
Colesevelam hydrochloride in the management of dyslipidemiaAnnemarie Armani, Peter P Toth
Current Medicinal Chemistry|August 11, 2012
Vasoactive compounds in the neonatal periodP Toth-Heyn, L Cataldi
European Heart Journal Open|August 21, 2024
It is time to address the contribution of cholesterol in all apoB-containing lipoproteins to atherosclerotic cardiovascular diseasePeter P Toth, Maciej Banach
Pageof 53

Showing results (41-50 of 524) with videos related to

Sort By:
Pageof 53
Clinical Therapeutics|November 9, 2004
Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalonePeter P Toth, Jason Urtis
Methodist Debakey Cardiovascular Journal|May 4, 2019
Statins: Then and NowPeter P Toth, Maciej Banach
Current Atherosclerosis Reports|August 12, 2009
Thienopyridine therapy and risk for cardiovascular events in secondary preventionPeter P Toth, Annemarie Armani
Ecotoxicology (London, England)|August 15, 2001
Development of DNA-based microsatellite marker technology for studies of genetic diversity in stressor impacted populationsP Dimsoski, G P Toth
Postgraduate Medicine|November 2, 2020
Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care systemPeter P Toth, Diane Gauthier
Current Atherosclerosis Reports|November 16, 2007
SPARCL: the glimmer of statins for stroke risk reductionAnnemarie Armani, Peter P Toth
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 1, 1994
Clozapine and seizures: a reviewP Toth, F R Frankenburg
Expert Review of Cardiovascular Therapy|May 24, 2006
Colesevelam hydrochloride in the management of dyslipidemiaAnnemarie Armani, Peter P Toth
Current Medicinal Chemistry|August 11, 2012
Vasoactive compounds in the neonatal periodP Toth-Heyn, L Cataldi
European Heart Journal Open|August 21, 2024
It is time to address the contribution of cholesterol in all apoB-containing lipoproteins to atherosclerotic cardiovascular diseasePeter P Toth, Maciej Banach
Pageof 53